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We studied the mechanisms underlying long-term functional recovery of hemiparkinsonian rats grafted intrastriatally with carotid body
(CB) cell aggregates. Amelioration of their motor syndrome is a result of the trophic actions of these grafts on the remaining ipsilateral
substantia nigra neurons rather than of the release of dopamine from the CB grafts. The grafts maintain a stable morphological appear-
ance and differentiated cell phenotype for the duration of the life of the host. Adult CB expresses high levels of glial cell line-derived
neurotrophic factor (GDNF) and the multicomponent GDNF receptor complex. These properties may contribute to the trophic actions of
the CB transplants on nigrostriatal neurons and to their extraordinary longevity. We show that CB glomus cells, although highly dopa-
minergic, are protected from dopamine-mediated oxidative damage because of the absence of the high-affinity dopamine transporter.
Thus, intrastriatal CB grafts are uniquely suited for long-term delivery of trophic factors capable of promoting restoration of the nigro-
striatal pathway.
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Introduction
Because Parkinson’s disease (PD) results primarily from degen-
eration of nigrostriatal neurons, intrastriatal transplantation of
dopamine-secreting cells has been used as a therapeutic approach
for this disorder (Lang and Lozano, 1998a,b; Rosenthal, 1998;
Dunnett and Bjorklund, 1999). Among the various dopaminergic
tissues tested in animal models of PD and in Parkinson’s patients,
allografts (and occasionally xenografts) of fetal mesencephalic
neurons are an efficacious therapy in humans (for review and
references, see Bjo¨rklund et al., 1987; Sladek and Gash, 1988;
Freed et al., 1992, 2001; Kordower et al., 1995; Deacon et al.,
1997). These pioneer transplantation studies have, however, set
the limitations of cell replacement therapies in PD. Intrastriatal
grafts of mesencephalic neurons increase dopamine concentra-
tion locally but have little restorative action on the nigrostriatal
pathway. Moreover, the use of human fetal cells raises numerous
ethical, legal, and practical issues (e.g., scarcity of human embry-
onic tissue), whereas the use of xenografts is hampered by the
need for sustained immunosuppression. Intracerebral adminis-
tration of trophic factors for dopaminergic neurons (Gash et al.,
1996; Choi-Lundberg et al., 1997; Rosenthal, 1999; Kordower et
al., 2000; Akerud et al., 2001) and autotransplantation of dopa-
minergic carotid body (CB) cell aggregates (Espejo et al., 1998;
Luquin et al., 1999; Mı´nguez et al., 2001) are two approaches that
have been developed recently in animal models to complement
fetal cell grafts.
The CBs contain neural crest-derived, highly dopaminergic
glomus cells, which function as arterial oxygen sensors releasing
dopamine in response to hypoxia (for review, see Lo´pez-Barneo
et al., 2001). Unlike many other organs, CBs were presumed to be
particularly well suited for intracerebral transplantation because
hypoxia, an environmental condition that is likely to be present
inside the grafts, makes the CB grow (McGregor et al., 1984).
Moreover, CBs offer potential clinical advantages because their
unilateral surgical resection has no significant side effects
(Honda, 1992) and therefore can be used for autografts. Intrastri-
atal transplants of CB cell aggregates are able to effect notable
histological and functional recovery of parkinsonian rats (Espejo
et al., 1998) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-treated monkeys (Luquin et al., 1999). In addition, a
pilot study on PD patients subjected to unilateral resection of the
CB and bilateral transplantation of the tissue into the putamen
has proven the feasibility and safety of this therapy in humans
(Mı´nguez et al., 2001).
Although results obtained so far with CB grafts are promising,
the mechanisms of action and long-term viability of the implants
remain unknown. Here, we show that amelioration of parkinso-
nian rats with CB transplants is a result of their trophic effect on
the ipsilateral nigrostriatal neurons rather than the local release of
dopamine. CB grafts have an extraordinary durability and can
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last almost the entire life of the animal. We demonstrate that the
adult CB expresses high levels of glial cell line-derived neurotro-
phic factor (GDNF), which may contribute to the longevity of the
grafts and to their trophic effect on nigrostriatal neurons. We also
show that CB glomus cells lack expression of the dopamine trans-
porter (DAT) and are resistant to dopamine-mediated oxidative
damage.
Materials and Methods
Unilateral 6-hydroxydopamine-induced substantia nigra lesion, CB graft-
ing, and chronic MPTP-treated mice. Female Wistar rats (250 –300 gm)
were housed at regulated temperature (22  1°C) in a 12 hr light/dark
cycle, with access ad libitum to food and water. General procedures to
produce unilateral 6-hydroxydopamine (6-OHDA) (Sigma, St. Louis,
MO) substantia nigra (SN) lesions and transplantation surgery in rats
were as described previously (Espejo et al., 1998; Toledo-Aral et al.,
2002). Parkinsonian animals received transplants 10 –15 d after SN le-
sion. For transplantation, carotid bodies were trimmed into pieces ap-
proximately one-third the size of the whole organ. A carotid body piece
was placed on 1 l of Tyrode’s solution and injected into the striatum
after stereotaxic coordinates in reference to bregma (in mm): anteropos-
terior (AP), 0.2; lateral (L), 3; ventral (V), 6. Sham-operated ani-
mals received only 1 l of Tyrode’s solution. Mice of the Swiss and
C57BL/6 strains received subcutaneous MPTP injections either daily
(5–30 mg/kg) or weekly (20 – 40 mg/kg) during 1 week to 3 months. All
experiments were performed according to the animal care guidelines of
the European Communities Council (86/609/EEC).
Histological analyses. Rat and mouse brains and carotid bifurcations
were removed and fixed overnight at 4°C with 4% paraformaldehyde in
PBS. Slices 30 –100 m thick were cut with a Vibratome (Vibratome, St.
Louis, MO). Histological analysis was as previously described (Nieto et
al., 1996; Pardal et al., 2000; Echevarrı´a et al., 2001). For immunohisto-
chemical studies, we used a polyclonal anti-tyrosine hydroxylase (TH)
antibody [1:1000; for rat, Chemicon (Temecula, CA); for mice, Pel-Freez
(Rogers, AR)] and a secondary anti-rabbit antibody (1:200; Pierce, Rock-
port, IL). The level of reinnervation by TH-positive fibers in the CB-
grafted striatum was estimated by measuring the percentage of reinner-
vated area compared with the intact contralateral side. To make this
calculation, all of the coronal sections of the striatum stained with the TH
antibody (10 –14 sections per animal) were photographed and digitized.
The areas of TH immunoreactivity in both the normal and the grafted
striatum of each slice were calculated by computer using the appropriate
tools of Canvas 6.0 (Deneba Systems, Miami, FL).
In situ hybridization against TH and DAT was done using digoxige-
nin UTP-labeled antisense riboprobes synthesized from two plasmids
(pCR2.1-TH and pRc/CMV-DAT) (Martres et al., 1998) containing
partial cDNA sequences for TH and DAT, respectively. After hybrid-
ization, the sections were incubated with alkaline phosphatase-
conjugated anti-digoxigenin antibody (1:1000; Roche Diagnostics,
Mannheim, Germany).
Under chloral hydrate anesthesia (350 mg/kg, i.p.), some rats received
Fluorogold (FG) (Fluorochrome, Denver, CO) injections 24 hr before
the brain was removed. Two stereotactic deposits of 0.1 l of a 4% Flu-
orogold solution in saline were done (AP1.3, L2.5, V5.5; and AP
0.9, L 3.5, V 5.5). Injections were made with a Stoelting (Wood
Dale, IL) infusion pump at a rate of 0.05 l/min. The cannula was left in
place for 10 min after each injection before being slowly retracted. Het-
erozygous GDNF/lacZ mice 4 months old were used for the 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-gal) staining (Sa´nchez et al.,
Figure 1. Long-term functional recovery of CB-grafted hemiparkinsonian rats. A, Evolution
of the rotational behavior in CB-grafted animals measured before the transplantation (BT ) or at
the end of the period they were allowed to survive (between 5 and 15 months) (AT ). Animals’
behavior was evaluated by the amphetamine (left ordinate) and apomorphine (right ordinate)
tests. Animals were classified in groups I and II depending on the behavioral and histological
characteristics (see Results). Apomorphine tests were done only on animals that had some
functional recovery in the amphetamine test to detect upregulation of dopamine receptors.
Behavioral status is as follows (mean SEM in turns per hour): group I, amphetamine test,
BT 787 171 (n 6) and AT 138 53 (n 6); apomorphine test, AT 3 5 (n
5); group II, amphetamine test, BT 1206 145 (n 6) and AT 872 179 (n 6);
apomorphine test, AT 328 133 (n 3). B, Same analysis as in A performed in the group of
4
sham-operated animals that rotated 900 turns per hour. Behavioral status is as follows
(mean SEM in turns per hour): amphetamine test, BT 671 54 (n 8) and AT 702
159 (n 8); apomorphine test, AT 298 27 (n 3). *p 0.02, statistically significant
with respect to BT in the same group (t test); **p 0.02, statistically significant with respect
to the same test in group II and in B (t test).
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1996). For colocalization studies, TH immunohistochemistry was per-
formed after the X-gal staining.
Behavior and pharmacological assessment. Hemiparkinsonian rats were
randomly allocated into two groups: grafted (n 16) and sham operated
(n 16). Within the first group, four animals were discarded later in our
analysis because the graft was either dead or located outside the striatum.
Amphetamine-induced (5 mg/kg, i.p.; Sigma) rotation was evaluated 8 d
after unilateral nigra lesion and 10 d after transplantation. Apomorphine
(0.5 mg/kg, s.c.; Sigma) tests were done only on animals that had some
functional recovery in the amphetamine test to detect upregulation of
dopamine receptors. Rats were tested monthly for rotational behavior
induced by amphetamine and when necessary by apomorphine
(Schwarting and Huston, 1996). Amphetamine and apomorphine tests
were alternated every 2 weeks. Rotations were measured in an automated
rotometer (Letica, Barcelona, Spain) after the injection. The parameter
used for analysis was the number of rotations during the hour of maxi-
mum effect of the drug. Values are given as mean SEM. The statistical
significance of differences among parameters was considered at a value of
p  0.05 (Student’s t test).
Molecular biology. To perform reverse transcription (RT)-PCR,
poly(A) RNA was extracted from either slices or intact carotid bodies
using the Dynabeads mRNA Direct micro kit (Dynal, Oslo, Norway) as
indicated by the manufacturer. Between 10 and 20 whole carotid bodies
or the equivalent amount of tissue from the superior cervical ganglion
(SCG) or the SN were used (Pardal et al., 2000; Echevarrı´a et al., 2001).
The reverse transcription reaction was performed immediately after the
mRNA isolation using SuperScript II RNase H reverse transcriptase
(Invitrogen, Carlsbad, CA). Standard PCR was done with 1–5 l of first-
strand cDNA. The primers used to amplify the different genes were as fol-
lows: for TH, sense, GGACATTGGACTTGCATCTCTGGG and antisense,
TGAGAAGCAGTGTTGGGAGGATGG; for GDNF, sense, TGAAGTTAT-
GGGATGTCGTGGCTG, antisense A, AAGTGTATTGCAGTTAAGACGC
(band of 372 bp), and antisense B, ATCCACACCGTTTAGCGGAATGC
(band of 627 bp); for GDNF family receptor1 (GFR1), sense, ATGTTC-
CTAGCCACTCTGTACTTCG and antisense, GGTTGCAGACCTCGTT-
GGACATGC; for c-ret, sense, GCGCCCCGAGTGTGAGGAATGTGG,
and antisense, GCTGATGCAATGGGCGGCTTGTGC (as by Moreau et al.,
1998); and for DAT, sense, TATAGAGACGCAATCATCACCAC and anti-
sense, AGCAGGAAAGTAGCCAGGACAAT. In every case, the band of the
expected size was gel purified and cloned into the pCR2.1 vector (Invitrogen,
Carlsbad, CA), and its identity was finally confirmed by sequencing using the
dideoxynucleotide chain termination method with the Sequenase 2.0 kit
(United States Biochemicals, Cleveland, OH). For TH, the partial sequence
of 599 bp amplified by PCR and cloned into the pCR2.1 vector was the one
used as a template to produce the antisense riboprobe after linearization of
the pCR2.1-TH.
Results
Functional recovery of CB-grafted animals depends on
nigrostriatal reinnervation
To perform this study, we prepared hemiparkinsonian rats with
extensive lesions of the left SN (991  64 ipsilateral turns per
hour in amphetamine test; n 32). Animals were left to recover
between 5 and 15 months after either CB transplantation (n 
16) or sham surgery (n 16) to study the long-term evolution of
the grafts. We found healthy grafts in80% of the animals that
received transplants, even if they were left to recover for7 (n
4) or 11 (n  2) months. The percentage of graft survival is
similar to that observed in animals killed within 3 months after
the surgery (our unpublished data), suggesting that the grafts of
CB tissue that overcome the transplantation trauma can main-
tain a stable phenotype for almost the entire life of the animal.
Functional recovery of the whole group of CB-transplanted
animals, estimated with the amphetamine test, was statistically
significant (in turns per hour, 1000 124 before transplantation
and 505 142 after transplantation; n 12; p 0.02). In con-
trast, the surgery had no significant behavioral effect on sham-
operated animals (in turns per hour, 999 76 before transplan-
tation and 737 119 after transplantation; n 16; p 0.2). On
the basis of the behavioral (apomorphine test) and histological
characteristics of the CB-grafted animals (see below), we classi-
fied them in two clearly distinct groups. Animals in group I had
an average 85% stable recovery in the amphetamine test and
did not rotate after administration of apomorphine (n 6) (Fig.
1A), indicating a truly good functional recovery after transplan-
tation with lack of dopamine supersensitivity. The analysis of the
time course of recovery indicated significant functional improve-
ment at 1 month (55%), which increased at 3 months (72%) and
was almost complete (81%) at 5 months. Later, functional recov-
ery remained stable or with slight additional improvement. Ani-
mals in group II manifested an asymmetrical sensitivity to apo-
Figure 2. Long-term striatal reinnervation and survival of substantia nigra neurons in ca-
rotid body-grafted rats. A–D, Striatal dopaminergic reinnervation in a representative animal of
group I killed 5.5 months after carotid body transplantation (AT ). BT, Before transplantation.
Normal ( A) and reinnervated ( B) striata are shown for comparison. Insets at high magnification
show the appearance of TH-positive striatal fibers. The region with the carotid body graft ( g) is
shown in C and D at higher magnifications. Note the numerous typical glomus cells in the graft
arranged in glomeruli. E, Localization of FG injection in the striatum near the graft. F, Retrograde
labeling of numerous cells in the ipsilateral substantia nigra. Midline is indicated by the dotted
line. A–E, Transmitted light and immunostaining with antibody against TH. E, F, UV illumina-
tion. Behavioral parameters of this animal (turns per hour) were as follows: amphetamine test,
BT 1512 and AT 111; apomorphine test, AT9. Striatal reinnervation, 70.7%.
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morphine and had a poor recovery in the
amphetamine test (n 6) (Fig. 1A), indi-
cating a striatal denervation with a com-
pensatory upregulation of dopamine re-
ceptors. Differences in the number of
turns per hour before transplantation be-
tween animals distributed later on in
groups I (787 171) and II (1206 145)
were not statistically significant. We fol-
lowed the parallel evolution of a group of
sham-operated hemiparkinsonian ani-
mals with a mean value of turns (671 54
turns per hour) comparable with that of
group I animals. On average, these sham-
operated animals did not recover in the
amphetamine test, and those with some
apparent amelioration manifested a clear
motor asymmetry in response to apomor-
phine (Fig. 1B). Thus, these data indi-
cated that long-term functional recovery
of hemiparkinsonian rats required the
presence of CB transplants in the
striatum.
Differences in the level of functional
recovery described above were correlated
with distinct degrees of histological resto-
ration (striatal reinnervation, 69.5 
3.7%, n 6 for group I; 4.9 2.2%, n 6
for group 2). Figure 2A–D illustrates the
appearance of the striata of a rat represen-
tative of group I after TH immunostain-
ing. Comparison of the unlesioned (A)
and transplanted (B) sides shows an im-
portant reinnervation that affects primar-
ily the central and medial regions of the
striatum. TH-positive fibers were particularly dense in the region
surrounding the graft, which appeared as a dense mass of in-
tensely stained TH-positive glomus cells (Fig. 2C) organized in
clusters similar to the glomeruli of the carotid body (Fig. 2D).
The origin of the dopaminergic fibers was studied by injection of
FG, a fluorescent retrograde tracer, in the striatum near the center
of the reinnervated area (Fig. 2E). Fluorescent cells were observed
in the ipsilateral SN, primarily in the medial region of the pars
compacta, and in the lateral part of the ventral tegmental area
(VTA) (Fig. 2F). With the exception of a few cells encountered in
the contralateral SN, TH-positive cells filled with FG were not
appreciable in the CB graft or anywhere else in the brain. This
distribution of FG-positive cells was repeated in the four group I
animals studied. Intrastriatal FG injection in four sham-operated
animals showed almost complete absence of fluorescent cells in
the SN (data not shown). These results show that functional re-
covery of CB-grafted animals is correlated with striatal reinner-
vation by fibers originating in ipsilateral nigrostriatal neurons.
The histological appearance of the nigrostriatal system in an-
imals with poor functional recovery (group II) is illustrated in
Figure 3. The striatum ipsilateral to the lesion was almost com-
pletely denervated (Fig. 3, compare A, B) despite the presence of
a large graft, well placed in the center of the striatum (Fig. 3B,C)
with numerous intensely stained glomus cells (Fig. 3D,E). Stria-
tal denervation was paralleled by an extensive destruction of ip-
silateral mesencephalic dopaminergic neurons, with an almost
absolute absence of TH-positive neurons in the SN and a marked
reduction of staining in the adjacent VTA (Fig. 3F–I). These
observations indicate that CB grafts by themselves are not suffi-
cient to reverse parkinsonian symptoms in animals with com-
plete nigra lesions. Together, the behavioral and histological
analyses indicate that the beneficial effect of CB grafts on parkin-
sonian animals is predominantly a result of their trophic effects
on the remaining SN neurons, which are induced to innervate the
striatum.
GDNF is highly expressed in adult CB cells
We studied whether CB cells are the source of the potent dopami-
notrophic factor GDNF and other members of the same family
(Rosenthal, 1999) that are retrogradely transported to stimulate
SN neurons. Using two different sets of primers derived from rat
GDNF sequences, we amplified, by RT-PCR, cDNA fragments
(of 372 and 627 bp) from carotid bodies and by sequencing con-
firmed them to be derived from rat GDNF (Lin et al., 1993). The
oligonucleotides flanking the 627 bp fragment were used repeat-
edly to amplify GDNF in all of the different CB preparations
tested (n  9) (Fig. 4A). Several parallel attempts (n  5) to
detect GDNF from the neighboring large SCG have failed (Fig.
4A). The other GDNF-related factors studied (neurturin, arte-
min, and persephin) were not amplified by RT-PCR of CB tissue.
However, the CB (n 4) and the SCG (n 3) expressed consis-
tently the multicomponent receptor complex for GDNF (GFR1
and c-ret) (Rosenthal, 1999).
GDNF is expressed in limited amounts during specific devel-
opmental stages by target tissues, and its presence in embryonic
rodent CB has been reported previously (Nosrat et al., 1996;
Figure 3. Lack of striatal reinnervation in carotid body-grafted animals with complete destruction of substantia nigra neurons.
Comparison of the normal ( A) and denervated ( B) striata in a representative animal of group II killed 5 months after carotid body
transplantation (AT ). Insets at high magnification show the appearance of TH-positive striatal fibers. Localization of the graft ( g)
is shown in C and in D and E at higher magnification. Note the large size of the graft with abundant glomus cells. Appearance of the
normal (F, H ) and lesioned (G, I ) substantia nigra in the same animal. Note the complete absence of dopaminergic cells in the
lesioned substantia nigra and the marked reduction of stained cells in the ventral tegmental area. Arrowheads in I indicate the track
of the needle used for 6-OHDA injection. Immunostaining with antibody against TH (A, B, D, F, G) and TH mRNA in situ hybridization
(C, E, H, I ). Behavioral parameters of this animal is as follows (turns per hour): amphetamine test, BT 1293 and AT 1473.
Striatal reinnervation, 2.1%.
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Erickson et al., 2001). The functional role of GDNF in the adult,
however, is less well studied, because its normal low level of ex-
pression, a characteristic of trophic factors, hampers its unequiv-
ocal identification by standard histological and/or immunologi-
cal techniques (in situ hybridization, immunostaining, or
ELISA). To study precisely the cell localization and the pattern of
GDNF expression in CB of adult animals, we used heterozygous
knock-out GDNF/lacZ mice, in which the cells expressing GDNF
can be labeled with the characteristic blue X-gal staining (Sa´nchez
et al., 1996). These experiments revealed that GDNF is highly
expressed in the adult CB but is totally absent in the SCG and
other neighboring tissues (Fig. 4B). Simultaneous X-gal and TH
immunostaining showed that GDNF-producing cells are colocal-
ized with clusters of TH-positive glomus cells (Fig. 4C,D). The
deposits of X-gal appear to be preferentially located in the periph-
ery of TH-positive cells (Fig. 4E,F) and occasionally surrounding
glomus cells (Fig. 4 F–H). These data demonstrate that GDNF is
highly and selectively expressed in CBs of adult rodents. The
pattern of CB GNDF expression is consistent with its presence in
glial-like subtentacular cells located in close apposition with glo-
mus cells.
Differential expression of DAT and susceptibility to
neurotoxins of SN neurons and CB glomus cells
The long-term functional recovery of transplanted rats was cor-
related with the survival of the CB tissue. Therefore, we studied
whether, in addition to the local effects of trophic factors, such as
GDNF, the survival of CB grafts could also
be facilitated by special features of dopa-
mine metabolism in glomus cells that pro-
tect them from oxidative stress.
The high-affinity presynaptic dopa-
mine reuptake system (DAT) plays a crit-
ical role in the susceptibility of SN neu-
rons to degeneration (for review, see
Jenner, 1998; Offen et al., 1999). Reuptake
of dopamine results in the production of re-
active oxygen species, which can induce
neuronal death (Spina and Cohen 1989;
Jenner, 1998; Offen et al., 1999). In addition,
DAT is used for presynaptic transport of
some molecules [e.g., MPP (methyl phe-
nylpyridinium)] with toxic effects (Burns
et al., 1983; Gainetdinov et al., 1997). Al-
though glomus cells contain and release
large amounts of dopamine (Pardal et al.,
2000; Lo´pez-Barneo et al., 2001), we hy-
pothesized that they should have reduced
DAT activity on the basis of our previous
observations on parkinsonian monkeys,
which had relatively well preserved ca-
rotid bodies despite their exposure to
large doses of systemically administered
MPTP (Luquin et al., 1999). Differential
expression of DAT on SN and CB was ini-
tially studied by in situ hybridization of
mesencephalic and CB slices. Figure 5A
illustrates that, although DAT was abun-
dantly expressed in SN neurons, it was not
detected in the CB. Consecutive slices in-
cubated with a TH probe show the high
levels of expression of the enzyme in both
SN and CB, demonstrating the stability of
the mRNA in the tissue. This experiment was repeated in SN and
CB preparations from 12 different animals with identical results,
suggesting that DAT is not present in CB cells. Additional sup-
port for this observation was obtained by high-sensitivity RT-
PCR analysis performed on carotid body and mesencephalic
slices, showing the complete absence of the DAT message in CB
cells (n  3 experiments) (Fig. 5B). To determine whether the
absence of DAT expression has a functional consequence, we
investigated whether glomus cells are protected from MPTP
damage. We compared the effects of the neurotoxin on TH-
positive mesencephalic and CB cells in two different MPTP-
sensitive mouse strains. Whereas chronic systemic administra-
tion of MPTP resulted consistently in a marked destruction of
substantia nigra and, to a lesser extent, VTA neurons, the CB
glomus cells remained intact in all cases (n 7) (Fig. 5C). These
data show that CB cells, although highly dopaminergic, are pro-
tected from toxicity associated with the dopamine uptake system.
Discussion
In this article, we show that the beneficial effects of intrastriatal
CB transplants in hemiparkinsonian rats are predominantly a
result of their trophic action on intrinsic nigrostriatal neurons
rather than their delivery of dopamine. Functional recovery,
which was maintained for the entire life of the CB-grafted rats, is
paralleled by the long-term survival of these CB grafts. We dem-
onstrated that GDNF is highly expressed in the adult CB. In con-
Figure 4. Identification and localization of GDNF and the GDNF multicomponent receptor complex in the carotid body. A,
RT-PCR showing the existence of GDNF and the high-affinity GDNF receptor complex (GFR1 and c-ret) in the CB. Note the parallel
experiment illustrating the absence of GDNF message in the SCG. TH is also amplified to test for mRNA stability. B, X-gal staining
(blue) of histological sections at the level of the carotid artery bifurcation from heterozygous GDNF/lacZ knock-out mice at two
magnifications illustrating the dense appearance of GDNF-positive cells in the CB and the complete absence of GDNF
expression in the SCG. C, Colocalization of GDNF (blue)- and TH (brown)-positive cells in the same glomeruli. Note that TH
immunostaining is absent from glomeruli without GDNF-positive cells (asterisks). D, Example at higher magnification of
colocalization of TH and GDNF expression. E–H, Localization of GDNF-positive cells in close apposition with TH-positive
cells. F–H, The focus was changed in steps of 4m to illustrate how some GDNF-positive cells (indicated by arrowheads)
are arranged juxtaposed on a glomus cell.
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trast, DAT, abundantly expressed in dopaminergic mesence-
phalic neurons, is absent from CB glomus cells, thus making
them resistant to dopamine reuptake-derived toxicity. These
properties of the glomus cells may contribute to the remarkable
longevity of the CB grafts and to their trophic actions on nigro-
striatal neurons.
For these experiments, we used hemiparkinsonian animals
with more extensive SN lesions (average number of ampheta-
mine-induced turns, 990 turns per hour) and studied them
for a longer time period (up to 15 months) than in our previous
work (Espejo et al., 1998; Toledo-Aral et al., 2002). One-half of
the CB-transplanted animals achieved an almost complete and
stable recovery of their motor asymmetries. Postmortem histo-
logical analysis of these animals demonstrated that they had in-
trastriatal CB grafts with numerous TH-positive cells and a
marked striatal dopaminergic reinnervation. In the remaining
50% of the animals with transplants, functional recovery was very
poor. Although this last group of animals had well placed, large
CB grafts with abundant metabolically active glomus cells, they
had almost complete striatal denervation in parallel with exten-
sive dopaminergic neuronal loss in the ipsilateral SN and adjacent
VTA. These observations suggest that, to obtain a good func-
tional recovery, CB-transplanted animals must retain a small per-
centage of dopaminergic SN neurons after the lesion such that the
grafted CB cells are able to induce the remaining SN neurons to
reinnervate the striatum. Intrinsic reinnervation has been postu-
lated to occur after adrenal grafts (Bohn et al., 1987; Hansen et al.,
1995; Gainetdinov et al., 1997) or in GDNF-injected rats (Rosen-
blad et al., 1998). The present study demonstrates directly that
the striatal reinnervation induced by CB grafts is produced by
fibers that originate almost exclusively in the ipsilateral SN and
adjacent VTA. The lack of long-term recovery of any of our
sham-operated animals indicates that striatal reinnervation does
not result from a nonspecific reaction to brain damage or gliosis
(but see Song and Haber, 2000).
The restorative activity of the CB grafts on nigrostriatal neu-
rons could be attributable to the graft-mediated delivery of
GDNF, which we showed to be highly expressed in adult CB
tissue, and possibly other trophic factors. At picomolar concen-
trations, GDNF is capable of promoting survival and differentia-
tion of mesencephalic dopaminergic neurons in vivo and in vitro
(Lin et al., 1993; Tomac et al., 1995a; Gash et al., 1996). Moreover,
GDNF delivered intrastriatally is taken up and transported retro-
gradely to the soma of SN neurons (Tomac et al., 1995b). Inter-
estingly, neurotrophin-3, another well known trophic factor
(Farin˜as et al., 1994), is also expressed in the CB (I. Farin˜as,
personal communication). Thus, CB grafts could offer stable and
regulated pumps ideal for the safe delivery of the proper mixture
of growth factors capable of promoting nigrostriatal sprout and
reinnervation. We did not see obvious changes in the morphol-
ogy of SN neurons in the side ipsilateral to the CB grafts com-
pared with neurons in the contralateral intact side. However,
elucidation of the biochemical and morphological modifications
induced by the trophic action of CB grafts on SN neurons re-
quires additional studies in a feasible and reproducible rodent
model of chronic and diffuse bilateral parkinsonism, which needs
to be developed.
A remarkable observation of our study is the extraordinary
longevity of CB grafts, which appear to be active for almost the
entire life of the animal. Glomus cells in the graft maintain a
stable phenotype and the typical organization in glomeruli char-
acteristic of the native CB. These properties may be attributable
to the fact that we implanted CB cell aggregates rather than dis-
persed cells, suggesting that, after transplantation, the CB tissue
has specific molecular and topological features that facilitate its
adaptation to the environment in the brain parenchyma. We
demonstrated that adult CB tissue expresses the GDNF multi-
component receptor complex (GFR1 and c-ret) (Rosenthal,
1999). Therefore, it is plausible that GDNF released from subten-
tacular cells has a trophic activity on glomus cells. In addition to
the bases for the paracrine effects of GDNF, we show that CB
Figure 5. Differential expression of dopamine transporter in substantia nigra and carotid
body cells. A, In situ hybridization in consecutive mesencephalic (SN ) and CB slices with probes
against DAT and TH mRNAs. DAT message was undetectable in CB slices. B, RT-PCR showing the
lack of expression of DAT in the carotid body and comparison with SN. TH mRNA was amplified
in parallel to demonstrate mRNA stability. C, TH immunohistochemistry of mesencephalic and
carotid body slices from control and MPTP-treated (30 mg/kg daily for 55 d) C57BL/6 mice. Note
that systemic administration of MPTP produced a marked destruction of dopaminergic SN neu-
rons but left intact CB glomus cells.
146 • J. Neurosci., January 1, 2003 • 23(1):141–148 Toledo-Aral et al. • Trophic Effect of CB Grafts on Parkinsonian Rats
glomus cells, although highly dopaminergic, do not express DAT
and are therefore not subjected to the oxidative stress inherent to
dopamine metabolism, which is an important factor in the
pathophysiology of PD (Spina and Cohen, 1989; Jenner, 1998;
Offen et al., 1999; Conway et al., 2001). Systemic administration
of MPTP in mice destroys most SN neurons but does not alter CB
cells. These observations explain why glomus cells are less af-
fected by MPTP than adrenal medulla or superior cervical gan-
glion cells (Ambrosio et al., 1990) and the relative preservation of
carotid bodies in chronic MPTP monkeys (Luquin et al., 1999).
The longevity of glomus cells could also be facilitated by their
physiological role as oxygen sensors, because it is known that
hypoxia, a deleterious condition in most tissues, makes the ca-
rotid body grow (McGregor et al., 1984; Lo´pez-Barneo et al.,
2001). Interestingly, hypoxia has also been shown to stimulate
proliferation, survival, and differentiation of dopaminergic neu-
ral precursors (Morrison et al., 2000; Studer et al., 2000).
In conclusion, we show that intrastriatal CB transplants in-
duce long-term cellular and functional recovery of hemiparkin-
sonian rats because of trophic restoration of the intrinsic nigro-
striatal pathway. CB cells in adult rodents express high levels of
GDNF but, although highly dopaminergic, are protected from
dopamine-mediated oxidative damage because of the absence of
the high-affinity dopamine transporter. These results should en-
courage studies designed to test the neuroprotective and restor-
ative effects of CB autotransplants in PD patients.
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